Newest COVID shots are 54% effective in preventing symptoms, CDC finds

By: Mike Stobbe, The Associated Press Posted: 12:02 PM CST Thursday, Feb. 1, 2024

NEW YORK (AP) — The latest versions of COVID-19 vaccines were 54% effective at preventing symptomatic infection in adults, according to the first U.S. study to assess how well the shots work.

Read this article for free:

or

Already have an account? Log in here »

To continue reading, please subscribe:

*First annual payment billed as $205.00 + GST for one year. This annual subscription will automatically renew at $233.00 + GST every 52 weeks (10% off the regular annual price of $259.35). Offer available to new and qualified returning subscribers only. Cancel any time.

NEW YORK (AP) — The latest versions of COVID-19 vaccines were 54% effective at preventing symptomatic infection in adults, according to the first U.S. study to assess how well the shots work.

Read unlimited articles for free today:

or

Already have an account? Log in here »

Hey there, time traveller!
This article was published 01/02/2024 (966 days ago), so information in it may no longer be current.

NEW YORK (AP) — The latest versions of COVID-19 vaccines were 54% effective at preventing symptomatic infection in adults, according to the first U.S. study to assess how well the shots work.

The shots became available last year and were designed to better protect against more recent coronavirus variants.

In Thursday’s study, the Centers for Disease Control and Prevention looked at 9,000 people who got tested for COVID-19 at CVS and Walgreens pharmacies, checking who tested positive and whether they had gotten a new shot or not.

FILE - A Moderna Spikevax COVID-19 vaccine is seen at a drugstore in Cypress, Texas, Sept. 20, 2023. On Thursday, Feb. 1, 2024, the Centers for Disease Control and Prevention said the updated COVID-19 vaccine was 54% effective at preventing symptomatic infection in adults. The shot became available last year as a replacement vaccine designed to better protects against more recent COVID variants. (Melissa Phillip/Houston Chronicle via AP, File)

The 54% finding is similar to what’s been reported in other countries, and it’s also about what was reported for an earlier vaccine version, said the Ruth Link-Gelles of the CDC, the study’s lead author.

Studies coming out later this year will assess how effective the shot was at preventing symptoms severe enough to send patients to a doctor’s office or hospital, she said.

The CDC recommends the new shots for everyone 6 months and older, but most Americans haven’t gotten them. The latest CDC data suggests only about 22% of U.S. adults have gotten the shots, and only 11% of children. The slow uptake meant that it took longer for researchers to gather enough data to assess how well the shots work, Link-Gelles said.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.